Form: 3

Initial statement of beneficial ownership of securities

July 15, 2013

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Shah Chetan
(Last) (First) (Middle)
8910 UNIVERSITY CENTER LANE, SUITE 660
(Street)
SAN DIEGO CA 92122
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/18/2013 		3. Issuer Name and Ticker or Trading Symbol
AETHLON MEDICAL INC [ AEMD ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 8,750,000 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Purchase Warrants 03/29/2012 03/29/2019 Common Stock 937,500 0.125 D
Common Stock Purchase Warrants 06/19/2012 06/19/2019 Common Stock 1,111,111 0.108 D
Common Stock Purchase Warrants 08/29/2012 08/29/2019 Common Stock 534,723 0.12 D
Common Stock Purchase Warrants 11/12/2012 11/12/2019 Common Stock 666,667 0.093 D
Common Stock Purchase Warrants 02/11/2013 02/11/2020 Common Stock 333,333 0.096 D
Common Stock Purchase Warrants 03/14/2013 03/14/2020 Common Stock 333,333 0.115 D
Common Stock Purchase Warrants 06/14/2013 06/14/2020 Common Stock 333,333 0.121 D
10% Convertible Note (1) 10/09/2013(2) Common Stock 3,465,909 0.088 D
Explanation of Responses:
1. Unpaid principal and accrued interest on the note are convertible at Dr. Shah's option into common stock only if the note is not repaid by October 9, 2013. In that event, unpaid principal and accrued interest may be converted into common stock at $0.088/share. In addition, upon conversion of the note, Dr. Shah would receive warrants to purchase that number of shares of common stock equal to 50% of the amount of principal and interest being converted divided by $0.088, with such warrants being exercisable at a price of $0.132/share.
2. Maturity date.
/s/ Chetan S. Shah, M.D. 07/12/2013
** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.